Specific inhibition of the classical complement pathway by C1q-binding peptides

Journal of Immunology

Volumn 167, Issue 12, 2001, Pages 7052-7059

  Roos, A ^a   Nauta, A J ^a   Broers, D ^a   Faber Krol, M C ^a   Trouw, L A ^a   Drijfhout, J W ^a   Daha, M R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN G; INHIBITOR PROTEIN; PROTEIN 2J; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CHIMPANZEE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT FIXATION; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SYNTHESIS; GRAFT REJECTION; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNE COMPLEX DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RHESUS MONKEY;

EID: 0035892756     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.12.7052     Document Type: Article

References (35)

1. Biology of the complement system
2. Complement and complement-regulatory proteins in renal disease
3. Intervention in the complement system: A therapeutic strategy in inflammation
4. The immunological barriers to xenotransplantation
5. Strategies for targeting complement inhibitors in ischaemia/reperfusion injury
6. In stroke, complement will get you nowhere
7. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
8. C1-esterase inhibitor: An anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema
9. Therapeutic inhibition of the complement system: Y2K update
10. Proteolytic activities of two types of mannose-binding lectin-associated serine protease
11. Immunoglobulin in the control of complement action
12. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library
13. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation
14. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons
15. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts
16. Identification and characterisation of C1q-binding phage displayed peptides
17. Regulation of the function of the first component of complement by human C1q receptor
18. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q
19. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway
20. Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicity
21. Inhibition of complement-mediated immune hemolysis by peptides derived from the constant domain of immunoglobulin
22. Synthetic peptides which inhibit the interaction between C I q and immunoglobulin and prolong xenograft survival
23. Sequential determination of ligands binding to discrete components in heterogeneous mixtures by iterative panning and blocking (IPAB)
24. C1q-binding peptides share sequence similarity with C4 and induce complement activation
25. H2-like immunoglobulin γ motifs present in the autoantigen calreticulin and interferes with complement activation
26. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q
27. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coil C1q-binding protein
28. Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein C1q
29. A recombinant homotrimer, composed of the a helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway
30. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin
31. C1q receptors
32. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
33. The globular head of C1q specifically recognizes surface blebs of apoptotic vascular endothelial cells
34. Complement activation after oxidative stress: Role of the lectin complement pathway
35. A keratin peptide inhibits mannose-binding lectin